Daniel P. Alford, MD, MPH
Professor, Medicine
Biography
Daniel P. Alford, MD, MPH is Professor of Medicine and Associate Dean of Continuing Medical Education at Chobanian and Avedisian School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is the Director of the BUSM Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program which has trained over 240,000 healthcare providers nationally. He is past-president of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA). He has been recognized as a “Champion of Change” by the White House and has received the American Medical Association’s “Award for Health Education”, the American Society of Addiction Medicine “Educator of the Year Award”, the American College of Physicians “Award for Distinguished Contributions to Behavioral Medicine” and the AMERSA “McGovern Award for Excellence in Medical Education”. His clinical, educational and research interests focus on managing opioid use disorders and safer and more competent opioid prescribing for managing pain.
Other Positions
- Associate Dean, Continuing Medical Education, Boston University Chobanian & Avedisian School of Medicine
- Director, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine
Websites
- BU Profile
- Safe and Competent Opioid Prescribing Education (SCOPE of Pain) Program
- Boston University School of Medicine CME office
- Immersion Training Program in Addiction Medicine
- CARE Unit Faculty
- Boston Medical Center Provider Profile
- Association for Medical Education and Research in Substance Abuse (AMERSA)
- Safe Opioid Prescribing Education Modules
- Safe Opioid Prescribing Resources
- Grayken Center for Addiction at Boston Medical Center
- ResearchGate
- Public Relations - BU Experts
Education
- Boston University, MD
- Boston University, MPH
- Connecticut College, BA
- Marietta College, BA
Publications
- Published on 9/20/2024
King DK, Ondersma SJ, McRee BG, German JS, Loree AM, Harlowe A, Alford DP, Sedotto RNM, Weber MK. Using Planned and Unplanned Adaptation to Implement Universal Alcohol Screening and Brief Intervention to Prevent Alcohol-Exposed Pregnancies in Four Primary Care Health Systems. Subst Use Addctn J. 2025 Apr; 46(2):439-451. PMID: 39305032.
Read at: PubMed - Published on 9/16/2024
Green FO, Harlowe AK, Edwards A, Alford DP, Choxi H, German JS, Ling D, Pawlukiewicz I, Peterson R, von Sternberg K, Velasquez MM. Multi-Level Approaches to Fetal Alcohol Spectrum Disorders Prevention Education and Training for Health Professionals. Subst Use Addctn J. 2025 Apr; 46(2):430-438. PMID: 39279760.
Read at: PubMed - Published on 5/31/2024
Laks J, Alford DP. Treatment of opioid use disorder in patients with liver disease. Clin Liver Dis (Hoboken). 2024; 23(1):e0207. PMID: 38831768.
Read at: PubMed - Published on 12/1/2023
Canfield J, Truong V, Bereznicka A, Bridden C, Liebschutz J, Alford DP, Saitz R, Samet JH, Walley AY, Lunze K. Evaluation of a student clinical research education program in addiction medicine. Ann Med. 2023 Dec; 55(1):361-370. PMID: 36629696.
Read at: PubMed - Published on 4/3/2023
Alford DP, German JS, Bangham C, Harlowe A, Greece J. Alcohol screening during COVID-19 surges in an urban health system the United States. Prev Med Rep. 2023 Jun; 33:102197. PMID: 37034300.
Read at: PubMed - Published on 2/2/2022
Walker DM, Childerhose JE, Chen S, Coovert N, Jackson RD, Kurien N, McAlearney AS, Volney J, Alford DP, Bosak J, Oyler DR, Stinson LK, Behrooz M, Christopher MC, Drainoni ML. Exploring perspectives on changing opioid prescribing practices: A qualitative study of community stakeholders in the HEALing Communities Study. Drug Alcohol Depend. 2022 04 01; 233:109342. PMID: 35151024.
Read at: PubMed - Published on 11/18/2021
Alford DP, Kim TW, Samet JH, Cruz AB, Brolin MF, Shanahan CW, Saitz R. Prevalence and Correlates of Positive Follow-up Screens in Primary Care for Unhealthy Alcohol and Other Drug Use After a Negative Screen. J Addict Med. 2022 Jul-Aug 01; 16(4):e219-e224. PMID: 34799491.
Read at: PubMed - Published on 8/17/2021
Larochelle MR, Cruz R, Kosakowski S, Gourlay DL, Alford DP, Xuan Z, Krebs EE, Yan S, Lasser KE, Samet JH, Liebschutz JM. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? J Gen Intern Med. 2022 Aug; 37(10):2365-2372. PMID: 34405344.
Read at: PubMed - Published on 1/25/2021
Roseen EJ, Kasali BA, Corcoran K, Masselli K, Laird L, Saper RB, Alford DP, Cohen E, Lisi A, Atlas SJ, Bean JF, Evans R, Bussières A. Doctors of chiropractic working with or within integrated healthcare delivery systems: a scoping review protocol. BMJ Open. 2021 01 25; 11(1):e043754. PMID: 33495261.
Read at: PubMed - Published on 1/8/2021
Laks J, Alford DP, Patel K, Jones M, Armstrong E, Waite K, Henault L, Paasche-Orlow MK. A National Survey on Patient Provider Agreements When Prescribing Opioids for Chronic Pain. J Gen Intern Med. 2021 03; 36(3):600-605. PMID: 33420560.
Read at: PubMed
View 81 more publications: View full profile at BUMC